Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria

J Cutan Pathol. 2004 Apr;31(4):323-9. doi: 10.1111/j.0303-6987.2004.0195.x.

Abstract

Background: During a clinical trial, we obtained 16 biopsies of skin eruptions induced by aspirin in patients with chronic idiopathic urticaria (CIU). In this setting, aspirin triggers skin eruptions through a well-established non-immunological mechanism involving the inhibition of cyclooxygenase type I. This presented the rare opportunity to evaluate histological features of a series of skin eruptions induced by a drug acting through a defined mechanism in a controlled experimental setting.

Objective: Histological analysis of 16 biopsies of skin eruptions induced by oral aspirin challenge in patients with CIU.

Design: Microscopic analysis of tissue sections.

Patients: 16 patients with CIU.

Results: Aspirin (up to 500 mg) induced a restricted range of histological responses with a classic pattern of urticarial tissue reaction occurring in the majority of (12 of 16) cases. Two biopsies showed an interstitial fibrohistiocytic (granuloma annulare-like) reaction pattern. One case showed only a sparse perivascular lymphocytic infiltrate, and paucicellular dermal mucinosis was observed in one case.

Conclusions: Polymorphism of histological patterns induced by aspirin suggests that in addition to the drug-specific mechanisms triggering drug eruptions, individual factors also play a role in determining the ultimate histological phenotype of a drug response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Aspirin / adverse effects*
  • Cyclooxygenase Inhibitors / adverse effects*
  • Dose-Response Relationship, Drug
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Skin / drug effects
  • Skin / pathology*
  • Urticaria / complications
  • Urticaria / pathology*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Aspirin